CS Paper Radar

Collapsibility of Performance Metrics in Clinical Predictive AI

João Matos, Ben Van Calster, Richard D. Riley, Paula Dhiman, Gary S. Collins

cs.LG cs.AI ·submitted 2026-08-31 10:43 UTC · v1

Abstract

Background: Population level assessments of predictive artificial intelligence (AI) can conceal performance disparities across subgroups. Fairness evaluations commonly rely on performance analyses across subgroups. However, some performance metrics are non-collapsible, meaning that the overall population performance value does not equal the weighted average of subgroup specific values. Objective: To examine the collapsibility properties of commonly reported performance metrics in predictive AI, with a focus on the area under the receiver operating characteristic curve (AUC, also known as c-statistic). Methods: We investigate the collapsibility of 15 performance metrics, either by expressing each metric as a linear combination of its stratum specific values or, where non-collapsible, by providing a counterexample inspired by Simpson's paradox as a formal disproof. Results: Five performance metrics (AUC, calibration intercept, calibration slope, expected calibration error, and Nagelkerke R^2) are shown to be non-collapsible, and ten (O:E ratio, logloss, Brier score, accuracy, F1-score, true positive rate, true negative rate, positive predictive value, negative predictive value, and net benefit) are shown to be collapsible. The AUC is shown to be non-collapsible because it decomposes into within- and cross-group AUC terms when subpopulations coexist, such that its overall value may fall outside the range of subgroup specific AUCs. Conclusions: Non-collapsibility of performance metrics has important consequences for reporting, model appraisal, and fairness evaluation. It can generate spurious differences between subgroup and overall performance, which may mislead fairness evaluations. Explicitly acknowledging and reporting the collapsibility properties of performance metrics improves both the interpretability and transparency of fairness assessments.

Closest papers

Nearest neighbours by meaning across the whole index.

Fairness Metrics based on the AUC in Clinical Predictive AI

cs.LG cs.AI ·2026-11-03 ·João Matos, Ben Van Calster, Richard D. Riley, Paula Dhiman, Gary S. Collins
similarity 0.71
Abstract

Fairness evaluation of clinical prediction models for binary outcomes often involves fairness metrics that compare the area under the receiver operating characteristic curve (AUC, or c-statistic) across subgroups. However, the AUC has been shown to be a non-collapsible metric, meaning that its subgroup specific and overall values are not directly comparable as often implicitly assumed. This raises important questions about how existing AUC-based fairness metrics should be used and interpreted. We examine eight AUC-based fairness metrics proposed in the literature, including: within-group AUC parity; cross-group AUC (xAUC) parity; gap-to-overall AUC; equity-scaled AUC; minimum-based metrics; $\mathrm{xAUC}^1$; $\mathrm{xAUC}^0$; and $\mathrm{xAUC}^1$ or $\mathrm{xAUC}^0$ parity. We characterise their estimands, relate them to the decomposition of overall AUC (into within- and cross-group components), and critically appraise them. We then illustrate their behaviour using simulations based on the EuroSCORE II, a clinical prediction model for in-hospital mortality. We recommend reporting an AUC matrix, containing the overall AUC and all within- and cross-group AUC components, alongside population characteristics. When fairness metrics are needed, we recommend reporting the within-group AUC parity, with cross-group AUC parity providing supplementary information but requiring caution due to its potential conflict with calibration. Metrics involving $\mathrm{xAUC}^1$ and $\mathrm{xAUC}^0$ have merit, summarising within- and cross-group AUCs into single values, but their interpretation is non-trivial, and they should be used with caution. Gap-to-overall AUC, equity-scaled AUC, and minimum-based metrics compare quantities that should not be compared and it is unclear how to operationalise them, making them not fit for purpose and generally not recommended.

0.23

Beyond Demographic Balance: Multi-Metric and Intersectional Evaluation of Fairness in MIMIC-IV Mortality Prediction

cs.LG ·2026-10-01 ·Abdullah Al Noman, Fahmid Al Rifat, Tahrima Hashem, Syed Muhammad Ibne Zulfiker, Rishov Paul +1 more
similarity 0.64
Abstract · NEurlPS TAE workshop 2026 accepted

Fairness conclusions in clinical prediction can depend strongly on both the metrics reported and the demographic resolution at which performance is evaluated. We revisit these evaluation choices for ICU mortality prediction on MIMIC-IV, comparing predictive-utility and subgroup-error metrics across several fairness interventions. As a complementary case study, we introduce a lightweight adaptation strategy that jointly balances ethnicity--gender--insurance representation without conditioning on mortality outcomes, allowing demographic representation balancing to be examined separately from outcome-conditioned or direct error-rate interventions. We evaluate its behavior at both marginal and corresponding three-way intersectional subgroup levels, while accounting for the statistical support of finer-grained estimates. The results show that interventions can receive substantially different assessments across accuracy/AUROC, sensitivity, and false-positive rate, and that marginal demographic summaries can conceal heterogeneous error profiles within their constituent intersections, including among larger subgroups. These findings highlight the importance of evaluating fairness interventions at both complementary metric and subgroup resolutions, while accounting for the intervention target and the reliability of subgroup estimates.

0.15

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.62
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29

Performance metrics in machine learning: a scenario-based guide from the confusion matrix to calibration, regression and uncertainty

cs.LG ·2026-11-05 ·Mehmet Baygin, Sengul Dogan, Turker Tuncer
similarity 0.59
Abstract · 41 pages, 7 figures, 23 tables, including appendices

Performance metrics can yield different conclusions from the same predictions. This methodological tutorial explains the effects of class prevalence, decision thresholds, aggregation rules and software conventions through controlled scenarios. Twenty-two confusion-matrix metrics are organized in a prevalence-coded map. Fifteen scenarios cover binary and multi-class classification, score discrimination, probability calibration, regression, uncertainty and consistency checks. Inputs are fixed in released files, and one factor is varied in each scenario. All 205 verification checks passed; 202 were independent and 3 were internal. An always-negative rule achieved an accuracy of 0.990 at a prevalence of 0.010, with balanced accuracy of 0.500. At fixed sensitivity and specificity, precision fell from 0.889 to 0.008 as prevalence fell from 0.5 to 0.001. Three probability variants shared a ROC-AUC of 0.825 but had calibration slopes of 2.08, 1.04 and 0.52. With 10 participants, participant-majority accuracy of 0.700 had a 95% interval of 0.348-0.933. Fold-averaged scores were falsely flagged as inconsistent under an inappropriate pooled-test-set model. A goal-based metric table and a reporting checklist are provided. The scenarios illustrate mechanisms and do not estimate their frequency in published studies. A literature audit and a real-data demonstration are specified as future protocols and were not executed.

0.31

Clinical predictions using artificial intelligence in neurosurgery and its subspecialties: a systematic review and meta-analysis

cs.AI q-bio.TO ·2026-11-09 ·Prajwal Ghimire, Aswin Chari, Jonathan Shapey, Keyoumars Ashkan
publishedsurvey similarity 0.58
Abstract

Artificial intelligence models for clinical prediction are proliferating across neurosurgery, but their aggregate discriminative performance, distribution along the care pathway and methodological quality are unclear. We systematically reviewed and meta-analysed these studies in neurosurgery and its subspecialities along with their risk of bias appraisal. We performed a PRISMA search for peer-reviewed original studies using AI to predict a clinical outcome in neurosurgical populations. Metrics were pooled using random effects modelling. Each study was classified as diagnostic, prognostic or forecasting and was assigned an evidence level. Clinical prediction task sub-stratification analysis was performed. Risk-of-bias was assessed using PROBAST. 1063 studies were included. Across 451 studies reporting AUC, pooled discrimination was 0.86, ranging from 0.84 (spine) to 0.87 (neuro-oncology), with extreme heterogeneity. Performance varied by clinical pathway stage, highest for diagnosis, grading and molecular tasks and lowest for post-operative tasks. Only 51 studies were using prospective data with external validation, whereas 619 rested on internal validation alone or no validation. 89 percent studies were at high risk-of-bias, driven by the analysis domain. AI models report high performance across all the neurosurgical subspecialities, concordant across AUC, accuracy, sensitivity and specificity and robust to risk-of-bias stratification. Performance is highest for imaging-anchored diagnostic tasks and lowest at decision-facing post-operative stage. However, the literature is dominated by optimism-prone, internally-validated and poorly calibrated models with extreme heterogeneity. External validation, calibration analysis and reporting guidelines adherence remain prerequisites for clinical adoption.

0.35

Clinical value claims in multimodal AI outpace supporting evidence

cs.LG cs.CY ·2026-10-09 ·Jiayu Feng
survey similarity 0.57
Abstract

Multimodal prediction models add a data source, such as imaging or an assay, to clinical information, and health systems must decide whether that added test is worth acquiring. We audited 177 studies comparing multimodal with unimodal models: 81 from a systematic review and 96 from a probability sample of 2025-2026 PubMed records. Gains in the area under the receiver operating characteristic curve (AUROC) were smaller when a study fitted a separate model for every data source (adjusted difference, -0.030; 95% CI, -0.056 to -0.005). Within 78 such studies, leaving out the strongest source's model would have raised the average gain from 0.046 to 0.108. This complete benchmarking fell from 69.1% of review studies to an estimated 46.0% of recent ones. An estimated 22% assessed decision utility and none evaluated a model prospectively, yet most claimed potential clinical usefulness or improved care (84.0% and an estimated 87.7%).

0.21

How to Run Statistics over LLM Judges and Trust the Results: Calibrated Inference for Small-Sample AI Evaluation with evalstats

cs.CL cs.AIcs.HCstat.ME ·2026-09-20 ·Ian Arawjo
code/data similarity 0.57
Abstract · 39 pages, 20 figures

Researchers across academia increasingly base significance claims on LLM judge scores and small-sample AI evaluations. Yet without well-calibrated confidence intervals (CIs), hypothesis tests, and judge-bias corrections, such claims are unreliable. We address these issues in several contributions. First, we find that running statistics over raw LLM judge scores leads to inflated false positives: counterintuitively, for many inter-rater agreement metrics, false positive risk peaks at "almost perfect" human-LLM agreement. To help researchers understand how to run statistics over LLM judges responsibly, we present guidance and tooling for the statistical analysis of mixed human-AI judge designs, and implement nine hypothesis tests via prediction-powered inference (PPI), including the first known PPI corrections for four rank-based tests (Wilcoxon signed-rank, Mann-Whitney U, and omnibus variants). To keep PPI++ stable with small human-labeled calibration sets, we introduce bootstrap-adaptive power tuning, which shrinks the estimated weight toward a target estimated from the labeled data, and accounts for that weight's own sampling variance. Second, through Monte Carlo simulations, we derive recommendations for what CI, p-value, and FWER correction methods to use for small-sample AI evaluations (N<100), and warn researchers against bootstrap CIs. We package these recommendations into evalstats, an open-source Python package that selects calibrated methods automatically, and demonstrate it in three scenarios, including one where a real LLM judge validated at "substantial agreement" would have led a researcher to publish a spurious finding. evalstats is publicly available at https://github.com/ianarawjo/evalstats.

0.44

VFR-Audit: Verdict-Level Reliability for Fairness Audits in Hospital Length-of-Stay Prediction

cs.AI ·2026-08-31 ·Md Jannatul Rakib Joy, Viet Vo, Caslon Chua
top venue similarity 0.57
Abstract · 12 pages, 5 figures. Accepted at the 35th ACM International Conference on Information and Knowledge Management (CIKM 2026)

Fairness audits in clinical Artificial Intelligence convert continuous fairness metrics into binary pass-or-fail verdicts against operational thresholds, where hospital governance boards, payers, and regulators act on the resulting verdicts. Such audits are repeated over time and across hospital sites, thus the same verdict can flip between pass and fail across audits. Existing uncertainty methods such as Bayesian posteriors, bootstrap confidence intervals, and permutation tests address verdict instability only at the continuous-metric level. Converting metric-level uncertainty into a verdict-stability claim remains a manual step that scales poorly across the (model, metric, attribute) cells an audit covers. Existing uncertainty methods also leave open whether bias-mitigation steps, such as reweighing or per-group threshold shifts, yield a stable passing verdict at the cost of model discrimination measured as AUROC or AUPRC.To address this verdict-stability gap, we propose VFR-Audit, a framework built around the Verdict Flip Rate (VFR), a scalar bounded between 0 and 0.5 that measures the probability of verdict reversal under stratified bootstrap resampling. VFR-Audit reports VFR alongside three reliability axes, namely within-cohort resampling stability, audit-size sensitivity, and cross-hospital verdict agreement via Fleiss' kappa.

0.36